ACN trades 11.7% above Wall Street's consensus target of $230.05.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ACN achieves its forward estimates and maintains a stable P/E multiple of 18.8x. This scenario reflects the blended consensus of 53 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 7, 2026, Accenture plc (ACN) has a Wall Street consensus price target of $230.05, based on estimates from 53 covering analysts. With the stock currently trading at $260.50, this represents a potential downside of -11.7%. The company has a market capitalization of $159.41B.
Analyst price targets range from a low of $175.00 to a high of $278.00, representing a 45% spread in expectations. The median target of $235.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 34 analysts rating the stock as a Buy or Strong Buy,18 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ACN trades at a trailing P/E of 21.4x and forward P/E of 18.8x. The forward PEG ratio of 2.08 reflects a premium valuation. Analysts expect EPS to grow -0.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $313.38, with bear and bull scenarios of $197.43 and $412.91 respectively. Model confidence stands at 63/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 IBMInternational Business Machines Corporation | $230.8B | $245.00 | $272.33 | +11.2% | Buy | 19.7x | 52 |
 CTSHCognizant Technology Solutions Corporation | $29.2B | $64.72 | $66.17 | +2.2% | Buy | 11.2x | 51 |
 WITWipro Limited | $21.4B | $2.16 | $7.35 | +240.3% | Hold | 0.2x | 21 |
 INFYInfosys Limited | $50.7B | $12.50 | $11.65 | -6.8% | Hold | 16.4x | 40 |
 EPAMEPAM Systems, Inc. | $8.3B | $159.31 | $119.18 | -25.2% | Buy | 12.1x | 37 |
 GGenpact Limited | $7.2B | $42.27 | $40.50 | -4.2% | Hold | 10.3x | 40 |
 EXLSExlService Holdings, Inc. | $6.5B | $43.15 | $45.33 | +5.1% | Buy | 18.3x | 19 |
 GLOBGlobant S.A. | $2.0B | $47.41 | $44.91 | -5.3% | Hold | 8.0x | 29 |
 LDOSLeidos Holdings, Inc. | $16.7B | $132.68 | $151.89 | +14.5% | Buy | 11.2x | 28 |
 SAICScience Applications International Corporation | $6.2B | $146.30 | $118.75 | -18.8% | Hold | 14.5x | 18 |
Quick answers to the most common questions about buying ACN stock.
ACN's consensus price target is $230.05, -11.7% below the current price of $260.5. The 53 analysts tracking ACN see downside risk at present valuations.
ACN has a consensus rating of "Buy" based on 53 Wall Street analysts. The rating breakdown is predominantly bullish, with 34 Buy/Strong Buy ratings. The consensus 12-month price target of $230.05 implies -11.7% downside from current levels.
With a forward P/E of 18.7871x, ACN trades at a relatively low valuation. The consensus target of $230.05 implies -11.7% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $278 for ACN, while the most conservative target is $175. The consensus of $230.05 represents the median expectation. Our quantitative valuation model projects a bull case target of $413 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ACN is heavily covered by Wall Street, with 53 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 34 have Buy ratings, 18 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ACN stock forecast based on 53 Wall Street analysts shows a consensus price target of $230.05, with estimates ranging from $175 (bear case) to $278 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $313, with bear/bull scenarios of $197/$413.
Our quantitative valuation model calculates ACN's fair value at $313 (base case), with a bear case of $197 and bull case of $413. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 63/100.
ACN trades at a forward P/E ratio of 18.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 21.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on ACN, with 1 Sell ratings and a price target of $230.05 (-11.7% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ACN analyst price targets range from $175 to $278, a 45% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $230.05 consensus represents the middle ground. Our model's $197-$413 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Bull/bear thesis, analyst target revisions, and earnings execution.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.